NCI Launches Lab Study on Ivermectin and Cancer Cells

Why the National Cancer Institute Is Studying Ivermectin
The National Cancer Institute (NCI) has confirmed it is conducting preclinical laboratory research into ivermectin’s potential ability to kill cancer cells. The study is part of early-stage scientific inquiry and does not mean ivermectin has been proven to treat cancer in humans. NCI Director Dr. Anthony Letai said there is enough public interest and preliminary laboratory research on the drug to justify a more rigorous preclinical evaluation. Results from the study are expected in the coming months.

What “Preclinical Research” Really Means
Preclinical research refers to testing conducted in laboratories before any trials in people are considered. Many substances show promise in test tubes or animal models but never become safe or effective treatments for humans. Health officials stress that ivermectin is not approved as a cancer treatment and that no clinical evidence currently supports its use against cancer. This stage of research is designed to determine whether further investigation is even warranted.

Why Ivermectin Has Drawn Public Attention
Ivermectin is an FDA-approved drug used to treat certain parasitic infections in humans and animals. It became widely discussed during the COVID-19 pandemic after being promoted by some groups as a treatment, despite studies showing it was ineffective for that purpose. More recently, claims circulating online have suggested ivermectin could treat cancer, contributing to patient questions and public debate.

Doctors Urge Caution for Patients
Oncologists report that some patients have considered using ivermectin instead of established cancer treatments after encountering claims on social media. Medical experts warn that delaying or abandoning proven therapies can seriously harm patient outcomes. The FDA has also cautioned that high doses of ivermectin can be dangerous.

What Comes Next
NCI officials emphasize that studying ivermectin does not mean endorsing it as a cure. The research is intended to evaluate claims using scientific methods while maintaining focus on evidence-based cancer treatments.